Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 2

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 2
---
 reasonable best efforts to arrange for the sale of the securities. We have agreed to pay to the placement agents the placement agent fees set forth in the table below, which assumes that we sell all of the securities offered by this prospectus supplement. There is no arrangement for funds to be received in escrow, trust or similar arrangement. There is no minimum number of shares of securities or minimum aggregate amount of proceeds that is a condition for this offering to close. We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund if we do not sell all of the securities offered hereby. Because there is no escrow account and no minimum number of securities or amount of proceeds, investors could be in a position where they have invested in us, but we have not raised sufficient proceeds in this offering to adequately fund the intended uses of the proceeds as described in this prospectus supplement. We will bear all costs associated with the offering. See “Plan of Distribution” on page S-12of this prospectus supplement for more information regarding these arrangements. Investment in our securities involves risks. See the section entitled “ Risk Factors” on page S-7of this prospectus supplement and the risk factors contained in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of certain factors which should be considered before investing in our securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                     |     | Per Share and 
 Accompanying  
 Warrants      |        |     | Total |               |
|:------------------------------------|:----|:--------------|-------:|:----|:------|--------------:|
| Offering price                      |     | $             |   1.65 |     | $     | 15,612,997.95 |
| Placement Agent Fees(1)             |     | $             | 0.0785 |     | $     |    742,909.88 |
| Proceeds, before expenses, to us(2) |     | $             | 1.5715 |     | $     | 14,870,088.07 |

| (1) | We have agreed to pay the placement agents a cash placement commission equal to seven percent (7.0%) of the                                                                                                                                      
 aggregate proceeds from